The second draft of the Environmental Protection Law is under review, with 12 new articles, including daily fines for enterprises. SAFE has removed approval requirements for service trade payments and the State Council has abolished or delegated 50 approval items
As 85 Chinese corporations make the Fortune Global 500 list, many are wondering how much power state-owned enterprises actually have. The government has stepped up its corruption crackdown and AstraZeneca has visited by the authorities amid the GSK bribery investigations
A series of high-profile investigations from the NDRC has led companies to worry about pricing. Early action when an investigation starts is crucial, as is awareness of how China's Anti-monopoly law works
A series of high-profile investigations from the NDRC has led companies to worry about pricing. Early action when an investigation starts is crucial, as is awareness of how China's Anti-monopoly law works
China outbound investment reaches $84 billion in a report from UN Trade and Development Conference and Hong Kong firms may be allowed to merge and advise on PRC law in Guangdong
The CSRC has released two Guidelines for the trading of treasury bond futures. The CIRC has also released Measures for dealing with insurance consumer complaints
Rising labour and land costs and stricter environmental regulations have caused German manufacturers to look at moving inland, but they are finding it hard to pick the right location
Rising labour and land costs and stricter environmental regulations have caused German manufacturers to look at moving inland, but they are finding it hard to pick the right location
The General Office of the State Council has released Opinions to adjust and upgrade the country's economic structure. The NDRC has identified key tasks for economic reform and SAFE has strengthened control of forex inflows in a new Circular
The CSRC has said it will release auditing papers to its counterparts in the US. Ping An insurance has purchased a London building for $388 million and the NDRC has launched another investigation, this time into drug pricing